This topic contains a solution. Click here to go to the answer

Author Question: What information should be shared with clients concerning the parameters of informed consent? ... (Read 20 times)

SAVANNAHHOOPER23

  • Hero Member
  • *****
  • Posts: 542
What information should be shared with clients concerning the parameters of informed consent?
 
  What will be an ideal response?

Question 2

What is the Khan Academy associated with?
 
  A. Islamic culture
  B. Flipped classrooms
  C. Decreased attention spans
  D. At-risk youth



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza77

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

Goals, risks, benefits, procedures, and limitations
Billing and fees (if applicable)
Confidentiality, rights, and limitations
Counselor training status
Involvement in supervision
Client's access to records
Client's rights to choose a counselor and be active in the counseling process
Client's rights to refuse counseling and implication of that refusal
Client's rights to additional questions about counseling and to have questions answered in comprehensible language

Answer to Question 2

B




SAVANNAHHOOPER23

  • Member
  • Posts: 542
Reply 2 on: Jul 30, 2018
YES! Correct, THANKS for helping me on my review


kilada

  • Member
  • Posts: 311
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library